Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, double-blind, randomized, active controlled, parallel group trial comparing the combinations of valsartan 80 mg plus hydrochlorothiazide 12.5 mg to valsartan 80 mg in patients with mild to moderate essential hypertension not adequately controlled with valsartan 80 mg.

Next Previous
Trial Profile

A multicenter, double-blind, randomized, active controlled, parallel group trial comparing the combinations of valsartan 80 mg plus hydrochlorothiazide 12.5 mg to valsartan 80 mg in patients with mild to moderate essential hypertension not adequately controlled with valsartan 80 mg.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 May 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 07 Nov 2011 Actual initiation date (Oct 2005) added as reported by ClinicalTrials.gov.
  • 07 Nov 2011 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
  • 14 Nov 2005 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top